Does TAMOXIFEN Cause Interstitial lung disease? 22 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Interstitial lung disease have been filed in association with TAMOXIFEN (Tamoxifen Citrate). This represents 0.2% of all adverse event reports for TAMOXIFEN.
22
Reports of Interstitial lung disease with TAMOXIFEN
0.2%
of all TAMOXIFEN reports
7
Deaths
10
Hospitalizations
How Dangerous Is Interstitial lung disease From TAMOXIFEN?
Of the 22 reports, 7 (31.8%) resulted in death, 10 (45.5%) required hospitalization.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TAMOXIFEN. However, 22 reports have been filed with the FAERS database.
What Other Side Effects Does TAMOXIFEN Cause?
Malignant neoplasm progression (1,499)
Metastases to bone (894)
Fatigue (729)
Nausea (611)
Metastases to liver (595)
Breast cancer (584)
Disease progression (571)
Breast cancer metastatic (515)
Diarrhoea (512)
Arthralgia (497)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which TAMOXIFEN Alternatives Have Lower Interstitial lung disease Risk?
TAMOXIFEN vs TAMSULOSIN
TAMOXIFEN vs TAPENTADOL
TAMOXIFEN vs TAPINAROF
TAMOXIFEN vs TARCEVA
TAMOXIFEN vs TARLATAMAB